Brokerages Set Nkarta, Inc. (NASDAQ:NKTX) PT at $14.67

Shares of Nkarta, Inc. (NASDAQ:NKTX) have earned an average rating of “Buy” from the eight research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $14.67.

Several research firms recently issued reports on NKTX. Stifel Nicolaus reduced their target price on shares of Nkarta from $15.00 to $14.00 and set a “buy” rating for the company in a report on Thursday, March 27th. Needham & Company LLC reduced their target price on shares of Nkarta from $11.00 to $10.00 and set a “buy” rating for the company in a report on Thursday. HC Wainwright reaffirmed a “buy” rating and set a $18.00 price objective on shares of Nkarta in a report on Thursday, March 27th. Finally, William Blair reaffirmed a “market perform” rating on shares of Nkarta in a report on Thursday.

Institutional Trading of Nkarta

Institutional investors have recently bought and sold shares of the stock. JPMorgan Chase & Co. lifted its position in Nkarta by 252.1% in the third quarter. JPMorgan Chase & Co. now owns 1,063,362 shares of the company’s stock worth $4,806,000 after buying an additional 761,349 shares during the last quarter. Wellington Management Group LLP lifted its position in Nkarta by 4.1% in the fourth quarter. Wellington Management Group LLP now owns 225,224 shares of the company’s stock worth $561,000 after buying an additional 8,883 shares during the last quarter. Sequoia Financial Advisors LLC bought a new stake in shares of Nkarta during the fourth quarter worth $31,000. American Century Companies Inc. lifted its position in shares of Nkarta by 8.8% during the fourth quarter. American Century Companies Inc. now owns 90,952 shares of the company’s stock worth $226,000 after purchasing an additional 7,378 shares during the last quarter. Finally, Affinity Asset Advisors LLC lifted its position in shares of Nkarta by 23.1% during the fourth quarter. Affinity Asset Advisors LLC now owns 800,000 shares of the company’s stock worth $1,992,000 after purchasing an additional 150,000 shares during the last quarter. 80.54% of the stock is currently owned by institutional investors.

Nkarta Trading Up 1.2%

Nkarta stock opened at $1.74 on Friday. The firm has a 50 day moving average of $1.79 and a 200 day moving average of $2.19. The firm has a market capitalization of $123.47 million, a price-to-earnings ratio of -0.93 and a beta of 0.81. Nkarta has a 12-month low of $1.31 and a 12-month high of $8.23.

Nkarta (NASDAQ:NKTX) last released its earnings results on Wednesday, May 14th. The company reported ($0.43) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.01. On average, analysts predict that Nkarta will post -1.7 EPS for the current year.

Nkarta Company Profile

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen that is in Phase 1 clinical trial for the treatment of relapsed/refractory (r/r) non-hodgkin lymphoma, as well as for lupus nephritis.